Financing - January 13, 2023
HVR Cardio closes a 11 million USD financing round
The Series B financing round of HVR Cardio was led by Finnish Innovestor Life Science Fund and Tesi. The Finnish cardiovascular device company HVR Cardio is developing a catheter-based solution CathHELIX, which makes it possible to repair the fault without the need for demanding open-heart surgery. The solution has already been granted Breakthrough Device Designation status by the […]
Biotech Business - December 21, 2022
Anocca secures 25 million EUR
Swedish Anocca has secured Venture Debt financing from the European Investment Bank (EIB). This significant investment recognizes the strength and high potential of Anocca and its transformational approach to developing T-cell therapies for cancer, the company states. “This financing supports us in moving our first generation of T-cell immunotherapies towards clinical trials in a solid […]
Acquisition - December 12, 2022
SynAct acquires TXP Pharma and carries out a directed share issue
SynAct Pharma has entered into a conditional agreement on acquisition of TXP Pharma, a Swiss-incorporated biotech company researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The purchase price consists of a fixed purchase price of SEK 136 million and a potential additional purchase price of SEK 55 million, where the […]
Biotech Business - October 19, 2022
Xbrane has carried out a directed share issue
The company has carried out a directed share issue of approximately 170 million SEK at a subscription price of SEK 72 per share. The subscription price was determined through an accelerated book-building procedure. A number of Swedish and institutional investors, including Systematic Group AB (Ashkan Pouya), Swedbank Robur Fonder, Cicero Fonder, TIN Fonder and Lancelot […]
Biotech Business - October 17, 2022
Takeda Ventures invests in Zelluna Immunotherapy
Zelluna Immunotherapy has announced an investment from Takeda Ventures, the strategic investing arm of Takeda. TVI investment joins Zelluna’s latest financing round, the company states. “We are delighted to have TVI as a strategic investor in Zelluna. The company has developed very well from its inception and made significant progress with our TCR-NK technology. This […]
Financing - October 17, 2022
Exact Therapeutics awarded 16 million NOK
Exact Therapeutics has announced that its collaboration partner GE Healthcare has been awarded with an innovation grant from the Norwegian Research Council (NRC) of 16 million NOK to support the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy. “We are very pleased with the award of this NRC grant, which brings […]
